UGT2B17 gene deletion associated with an increase in bone mineral density similar to the effect of hormone replacement in postmenopausal women

[11] Sun D(2007)Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk Urology 70 374-379

[12] Daly A(2010)Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer Canc Epidemiol Biomarkers Prev 19 229-239

[13] Schulze JJ(2008)Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis Am J Hum Genet 83 663-674

[14] Lundmark J(2008)Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents CMAJ 178 1660-1668

[15] Garle M(2000)The genetics of osteoporosis: ‘complexities and difficulties’ Clin Genet 57 161-169

[16] Skilving I(2009)Genes and osteoporosis: time for a change in strategy Int J Clin Rheumatol 4 221-233

[17] Ekstrom L(2008)Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study Lancet 371 1505-1512

[18] Rane A(2004)Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15 Genomics 84 707-714

[19] Jakobsson J(2009)Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism Hum Mutat 30 1310-1319

[20] Ekstrom L(1991)Relative risk factors for osteoporotic fracture: a pilot study of the MEDOS questionnaire Clin Rheumatol 10 49-53

[11] Sun D(2007)Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk Urology 70 374-379

[12] Daly A(2010)Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer Canc Epidemiol Biomarkers Prev 19 229-239

[13] Schulze JJ(2008)Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis Am J Hum Genet 83 663-674

[14] Lundmark J(2008)Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents CMAJ 178 1660-1668

[15] Garle M(2000)The genetics of osteoporosis: ‘complexities and difficulties’ Clin Genet 57 161-169

[16] Skilving I(2009)Genes and osteoporosis: time for a change in strategy Int J Clin Rheumatol 4 221-233

[17] Ekstrom L(2008)Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study Lancet 371 1505-1512

[18] Rane A(2004)Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15 Genomics 84 707-714

[19] Jakobsson J(2009)Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism Hum Mutat 30 1310-1319

[20] Ekstrom L(1991)Relative risk factors for osteoporotic fracture: a pilot study of the MEDOS questionnaire Clin Rheumatol 10 49-53